News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 2429
- Sources here
- 16
- Companies here
- 24
Search results
Stored financial headlines
Active search
2429 matching headlines
Ticker or company: BRIMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Nut Tree Capital (BRSP) discloses 1.5% BrightSpire Capital stake in 13G/A
Nut Tree Capital, through its affiliated entities, has reported a beneficial ownership of 1.5% in BrightSpire Capital, Inc.'s Class A common stock, totaling 1,937,826 shares. This disclosure was made in a Schedule 13G/A filing with the SEC, indicating shared voting and dispositive power over …
BRSP
main company
Sharemaestro market context
Price below Trend Line
52 weeks -5.6% · Next-week setup positive 58.0%
Fabric.AI (FABC) CEO Joshua Silverman receives 358,565-share stock grant
Fabric.AI (FABC) CEO Joshua Silverman was granted 358,565 restricted shares of common stock under the company's Long-Term Incentive Plan. The shares vest in four equal tranches, with the first two having already vested on June 18 and June 30, 2026, and the remaining two …
FABC
main company
Sharemaestro market context
Price below Trend Line
52 weeks -60.0% · Next-week setup negative 38.6%
Bridgeline Digital Ties Record New Customer Wins as AI Search Demand Accelerates
Bridgeline Digital reported strong fiscal third-quarter 2026 results, tying a company record with nine new customer wins and expanding relationships with ten existing accounts, driven by accelerating demand for its AI-powered HawkSearch platform. Core product revenue grew 13% on a trailing twelve-month basis, now …
BLIN
main company
Sharemaestro market context
Trend signal active
52 weeks -28.6% · Next-week setup negative 40.7%
M3-Brigade Acquisition VI Corp. (MBVI) earns $5.9M H1 income from SPAC trust
M3-Brigade Acquisition VI Corp. (MBVI), a Cayman Islands SPAC, reported a net income of $5.9 million for the first half of 2026, primarily driven by $6.2 million in interest income from investments in its U.S. Treasury-focused Trust Account. Despite this income, the company's management …
MBVI
main company
Sharemaestro market context
Trend signal active
44 weeks +1.2% · Next-week setup negative 39.1%
BRINKER INTERNATIONAL, INC SEC Filing (Aug 14, 2026)
This article details an SEC Form 144 filing by BRINKER INTERNATIONAL, INC. (EAT) on August 14, 2026. The filing indicates a proposed sale of 16,220 shares of common stock with an aggregate market value of $3,831,504.42, acquired through restricted stock vesting on August 13, …
EAT
main company
Sharemaestro market context
Trend signal active
52 weeks +57.7% · Next-week setup positive 58.1%
Kolibri Global Energy Inc. Announces Another Record for Its Highest Quarterly Revenue of $22.5 Million With a 46% Production Increase and a 197% Net Income Increase for the Second Quarter of 2026
Kolibri Global Energy Inc. reported a record quarterly revenue of $22.5 million for Q2 2026, marking a 109% increase from the previous year. This surge was driven by a 46% rise in production, reaching 4,690 BOEPD, and a 41% increase in average prices. The …
KGEI
main company
Sharemaestro market context
Trend signal active
52 weeks +3.2%
Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma
Bristol Myers Squibb's drug, iberdomide (Zenbexus), has received accelerated FDA approval for treating multiple myeloma, making it the first FDA-approved cereblon-modulating (CELMoD) protein degrader. Zenbexus is indicated for use with Darzalex Faspro and dexamethasone in adults who have received at least one prior line …
BMY
main company
Sharemaestro market context
Trend signal active
52 weeks +38.1%
Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Bristol Myers Squibb (BMY) is back in focus after the FDA granted accelerated approval for ZENBEXUS in a multiple myeloma combination regimen, introducing …
Sharemaestro market context Trend signal active 52 weeks +58.2% · Next-week setup positive 55.1%American Century group (GBX) discloses 5.7% beneficial stake in Greenbrier
American Century entities, including American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research, have reported significant beneficial ownership in The Greenbrier Companies, Inc. common stock. The American Century ETF Trust holds 5.5% (1,692,268 shares), …
GBX
main company
Sharemaestro market context
Price below Trend Line
52 weeks -2.3% · Next-week setup positive 60.2%
Bright Minds Biosciences (DRUG): Cormorant Asset Management reports 9.17% ownership stake
Cormorant Asset Management, LP and Bihua Chen have reported a significant ownership stake of 9.17% in Bright Minds Biosciences Inc. This beneficial ownership translates to 900,000 Common Shares out of 9,812,061 shares outstanding as of May 15, 2026. The reporting persons share voting and …
DRUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +73.9% · Next-week setup negative 43.1%
Cellebrite DI (NASDAQ:CLBT) Given New $16.00 Price Target at JPMorgan Chase & Co.
JPMorgan Chase & Co. has lowered its price target for Cellebrite DI (NASDAQ:CLBT) from $20.00 to $16.00, while maintaining an "overweight" rating. This new target implies a potential upside of 45.79% from the stock's current price of $10.97. Other analysts have also adjusted their …
CLBT
main company
Sharemaestro market context
Price below Trend Line
52 weeks -30.9%
Seabridge Gold (NYSE: SA) posts $117.5M Q2 profit and advances KSM work
Seabridge Gold reported a significant increase in Q2 2026 net income to $117.5 million, largely due to gains from spinning out the Courageous Lake project. The company is actively advancing its KSM project with major field programs and infrastructure development, supported by a newly …
Sharemaestro market context Price above Trend Line 52 weeks +116.7%Suncor or Enbridge? Here’s the Better Dividend Stock This Year
This article compares Suncor Energy and Enbridge as dividend stock investments. While Enbridge offers a higher current yield and more stable operations, Suncor is highlighted for its strong balance sheet, potential upside from elevated energy prices, and aggressive share buybacks, making it the preferred …
ENB
main company
Sharemaestro market context
Trend signal ended
52 weeks +10.5% · Next-week setup positive 59.7%
Enbridge Inc. stock rises Friday, outperforms market
Enbridge Inc. (ENB) saw its stock rise by 0.16% to C$70.61 on Friday, outperforming the broader Canadian market where the S&P/TSX Composite Index fell by 0.08%. Despite this gain, the company's stock closed 12.4% below its 52-week high of C$80.65, achieved on May 22nd.
ENB
main company
Sharemaestro market context
Trend signal ended
52 weeks +10.5% · Next-week setup positive 59.7%
Large proposed sale of 42.9M EAT shares disclosed in Form 144 filing
An affiliate of Brinker International (EAT) has filed a Form 144, signaling an intent to sell approximately 42.9 million common shares through Fidelity Brokerage Services LLC on the NYSE, with a proposed sale date of August 14, 2026. The filing also details restricted stock …
EAT
main company
Sharemaestro market context
Trend signal active
52 weeks +57.7% · Next-week setup positive 58.1%
BridgeBio Stock Has Soared 29% in Just 3 Months. Here's Why Wall Street Thinks It Could Go Even Higher.
One of the more high-flying stocks in the U.S. biotech sector these days is genetic-disease-focused BridgeBio Pharma (NASDAQ: BBIO). That's due almost entirely to the outperformance of its Attruby heart medication. If the generally bullish analyst sentiment on the company is anything to go …
BBIO
main company
Sharemaestro market context
Trend signal active
52 weeks +62.7% · Next-week setup positive 55.2%
Should You Continue to Hold ACHC Stock at an 18.17X P/E Valuation?
Acadia Healthcare Company, Inc.ACHC benefits from strong long-term demand for behavioral health services. The company is expanding its network through joint ventures, de novo facilities and bed additions. Shares of ACHC have surged 113.1% year to date, significantly outperforming the industry's 13.2% growth during …
BTSG
main company
Sharemaestro market context
Trend signal active
52 weeks +148.1% · Next-week setup positive 64.7%
BridgeBio Pharma's Transition to Rare Disease 'Commercial Powerhouse' On Track, RBC Says
BridgeBio Pharma's (BBIO) transition into a rare disease "commercial powerhouse" is on track and poised to accelerate, RBC Capital Markets said in a Friday note.The company's Attruby drug is gaining traction in first-line treatment settings, while the market for the drug Silver Upgrade to …
BBIO
main company
Sharemaestro market context
Trend signal active
52 weeks +62.7% · Next-week setup positive 55.2%
CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd.
SueWallSt has initiated an investigation into potential securities law violations by Cellebrite DI Ltd. (NASDAQ: CLBT) following a significant drop in its share price. The investigation stems from Cellebrite's Q2 2026 revenue falling below analyst expectations and the company subsequently lowering its full-year 2026 …
CLBT
main company
Sharemaestro market context
Price below Trend Line
52 weeks -30.9%
Cellebrite DI (CLBT) Cuts Guidance And Changes CEO, Is The Stock Now Cheap?
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Cellebrite DI (CLBT) has come under fresh scrutiny after its August 13 Q2 2026 earnings report, guidance cut, and CEO transition, with Levi …
CLBT
main company
Sharemaestro market context
Price below Trend Line
52 weeks -30.9%